Wuhan Hvsen Biotechnology Co.,Ltd. is involved in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. The company provides tylvalosin tartrate powders, and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products, as well as Tildipirosin. It produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.
Frequently asked questions
What sector does Wuhan Hvsen Biotechnology Co Ltd (300871) operate in?
Wuhan Hvsen Biotechnology Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Wuhan Hvsen Biotechnology Co Ltd (300871) current stock price?
As of the latest data, Wuhan Hvsen Biotechnology Co Ltd stock price is CN¥23.21, with a previous close of CN¥23.21.
What is Wuhan Hvsen Biotechnology Co Ltd (300871) current market capitalization?
Wuhan Hvsen Biotechnology Co Ltd market cap is approximately 4.68 billion.
What is Wuhan Hvsen Biotechnology Co Ltd (300871) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.43, and the forward EPS is CN¥1.29.
What is Wuhan Hvsen Biotechnology Co Ltd (300871) Price-to-Earnings (P/E) ratio?
Wuhan Hvsen Biotechnology Co Ltd current P/E ratio is 16.23, with a forward P/E of 17.99.
Does Wuhan Hvsen Biotechnology Co Ltd (300871) pay dividends?
Yes. Wuhan Hvsen Biotechnology Co Ltd pays semiannual dividends with an annualized yield of 1.72% and an estimated annual payout of CN¥0.40 per share.
When is the next ex-dividend date for Wuhan Hvsen Biotechnology Co Ltd (300871)?
The next ex-dividend date is scheduled for January 06, 2027.
What is Wuhan Hvsen Biotechnology Co Ltd (300871) beta (volatility) score?
Wuhan Hvsen Biotechnology Co Ltd has a beta of 0.588, indicating lower volatility than the overall market.
